Crestline Management’s MediciNova MNOV Stock Holding History

Crestline Management’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-99,206	Closed	-$1.01M	–	269
2018 Q1	$1.01M	Buy	+99,206	New	+$988K	0.13%	150

Other funds holding MNOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Crestline Management's MNOV Position: Q2 2018 in Review

Crestline Management sold out of MediciNova (MNOV) in Q2 2018, closing a stake of 99,206 shares — an estimated $1.01M sold.

Crestline Management first reported a position in MNOV in Q1 2018 and held it in 1 quarter. The position peaked at $1.01M in Q1 2018. 55 funds tracked by Wall St. Rank hold MNOV as of Q2 2018.

Crestline Management reported no remaining MediciNova position as of Q2 2018 after selling out during the quarter.
Crestline Management sold 99,206 MediciNova shares in Q2 2018, an estimated $1.01M.
Crestline Management first reported a position in MediciNova in Q1 2018 and held it in 1 quarter.
Crestline Management's MediciNova position peaked at $1.01M in Q1 2018.
55 funds tracked by Wall St. Rank held MediciNova as of Q2 2018.

Based on Crestline Management's 13F filing for Q2 2018, filed 14 Aug 2018.